Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.

9 Despite methodological concerns, the ESPAC‐1 trial was influential and partly accounted for a decreasing trend in utilization of adjuvant radiation in the US. 10 , 11 At present, adjuvant radiation is used selectively in patients that are thought to be at high risk for locoregional failure (ie, margin and/or node positivity).

also in 47,180 other papers